Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | ADH1B | P00325 | 2/20 | 0.36 |
| ▸ | ADH1C | P00326 | 2/20 | 0.36 |
| ▸ | ADH1A | P07327 | 2/20 | 0.36 |
| ▸ | ADH7 | P40394 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 11/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7488988 | 0.79 | DGKA (0.62) | DGKAADH1BADH1CADH1AADH7 | |
| SCHEMBL9099964 | 0.79 | DGKA (0.56) | DGKAADH1BADH1CADH1AADH7 | |
| SCHEMBL1401272 | 0.78 | DGKA (0.40) | DGKAADH1BADH1CADH1AADH7 | |
| SCHEMBL7367625 | 0.77 | ADH1B (0.39) | DGKAADH1BADH1CADH1AADH7 | |
| SCHEMBL8176277 | 0.76 | CYP1A2 (0.52) | DGKAADH1BADH1CADH1AADH7 | |
| SCHEMBL5528695 | 0.75 | ADH1B (0.50) | DGKAADH1BADH1CADH1AADH7 | |
| SCHEMBL9808672 | 0.75 | ADH1B (0.42) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL11788415 | 0.75 | ADH1B (0.50) | DGKAADH1BADH1CADH1AADH7 | |
| SCHEMBL11719964 | 0.74 | DGKA (0.65) | DGKAADH1BADH1CADH1AADH7 | |
| SCHEMBL18265597 | 0.74 | DGKA (0.65) | DGKAADH1BADH1CADH1AADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1239868-A2 | USE OF AN IMMUNOSUPPRESSANT FOR INCREASING AN ANTIFUNGAL ACTIVITY OF A LIPOPETIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-09-18 | — | — | EP | disclosed |
| EP-1223969-A2 | COMBINED USE OF A PLASMINOGEN ACTIVATOR AND IL-2 INHIBITORS FOR NEUROPROTECTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-24 | — | — | EP | disclosed |
| EP-1221938-A2 | METHOD FOR PRODUCING LIPOSOME PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-17 | — | — | EP | disclosed |
| EP-1183028-A2 | NEW USE OF MACROLIDE COMPOUNDS FOR INDUCING CHONDROGENIC DIFFERENTIATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-06 | — | — | EP | disclosed |
| EP-1126845-A2 | NEW USE OF IMMUNOSUPPRESSANTS FOR MMP-MEDIATED DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-29 | — | — | EP | disclosed |
| WO-2001041780-A2 | USE OF AN IMMUNOSUPPRESSANT FOR INCREASING AN ANTIFUGAL ACTIVITY OF A LIPOPEPTIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-14 | — | — | WO | disclosed |
| WO-2001028522-A2 | METHOD FOR PRODUCING LIPOSOME PREPARATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-04-26 | — | — | WO | disclosed |
| EP-1093371-A1 | USE OF FK506 AND RELATED MACROLIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OR PREVENTION OF PAIN | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-04-25 | — | — | EP | disclosed |
| WO-2001026605-A2 | IMMUNOSUPPRESSIVE COMPOSITION CONTAINING IL-2 INHIBITOR AND AN ADENOSINE DEAMINASE INHIBITOR | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-04-19 | — | — | WO | disclosed |
| WO-2001024784-A2 | NEW USE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-04-12 | — | — | WO | disclosed |
| WO-2000074665-A2 | NEW USE OF MACROLIDE COMPOUNDS FOR INDUCING CHONDROGENIC DIFFERENTIATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-12-14 | — | — | WO | disclosed |
| EP-1056454-A1 | USE OF MACROLIDE COMPOUNDS FOR TREATING GLAUCOMA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-12-06 | — | — | EP | disclosed |
| WO-2000015208-A2 | NEW USE OF IMMUNOSUPRESSANTS FOR MMP-MEDIATED DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-03-23 | — | — | WO | disclosed |
| WO-2000007594-A1 | USE OF IL-2 INHIBITORS IN THE TREATMENT OF RHEUMATOID ARTHRITIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-02-17 | — | — | WO | disclosed |
| WO-2000001385-A1 | USE OF FK506 AND RELATED MACROLIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OR PREVENTION OF PAIN | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-01-13 | — | — | WO | disclosed |
| WO-1999051215-A2 | IMMUNOSUPPRESSIVE IMIDAZOLE DERIVATIVES AND THEIR COMBINATION PREPARATIONS WITH TACROLIMUS OR CYCLOSPORINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-10-14 | — | — | WO | disclosed |
| WO-1999044597-A2 | USE OF MACROLIDE COMPOUNDS FOR THE TREATMENT OF ARDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-10 | — | — | WO | disclosed |
| WO-1999042104-A1 | USE OF MACROLIDE COMPOUNDS FOR TREATING GLAUCOMA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-08-26 | — | — | WO | disclosed |
| EP-0851753-A1 | AEROSOL COMPOSITIONS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-07-08 | — | — | EP | disclosed |
| WO-1997010806-A1 | AEROSOL COMPOSITIONS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-03-27 | — | — | WO | disclosed |